Graphite India Q3 FY26 results: Revenue up 24% YoY, PAT at Rs 100 Cr

Revenue Growth 20pctExceptional ItemEbitda Margin ExpansionResults View source PDF Explain this filing

GRAPHITE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.0%Reaction day

₹619.50

prior close

₹623.80

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+2.5%+0.4% vs market

Electrodes & Refractories peers, median of 10sector+1.3%+1.7% vs sector

On the reaction day the stock moved 0.4 pts more than Nifty Smallcap 250 and 1.7 pts more than its Electrodes & Refractories peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.8

10m

+0.4

15m

+0.7

30m

+0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.0+2.5+0.4+1.3+1.7

Next day

+7.4+3.1+4.4+4.4+3.1

+7.5+3.2+4.4+2.8+4.7

+8.4+2.4+6.0+0.9+7.6

+3.7+0.8+2.9-0.6+4.3

+8.3+0.7+7.5+0.7+7.6

+11.7+2.0+9.7+0.2+11.5

15d

+14.4-1.8+16.2-5.4+19.9

+1.6-5.0+6.7-10.8+12.5

+3.0-2.3+5.3-8.7+11.7

+18.0+8.8+9.2-1.5+19.5

UpDownMarket · Nifty Smallcap 250Sector · Electrodes & Refractories peers, median of 10Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Graphite India reported Q3 FY26 standalone revenue of Rs 643 Cr, up 24% YoY from Rs 517 Cr. PAT rose to Rs 100 Cr from just Rs 3 Cr in Q3 FY25. For 9M FY26, revenue grew 12% to Rs 1,996 Cr but PAT fell 14% to Rs 337 Cr versus Rs 390 Cr, partly due to a Rs 27 Cr one-time exceptional charge for new labour codes. Margins improved sharply in Q3 helped by better electrode pricing.

Likely market impact

Strong Q3 revenue growth and PAT recovery signal improving electrode pricing, though 9M PAT decline and one-time labour code charge may cap near-term upside.